Edward Loftus, MD
Gastroenterology · Rochester, MNNPI 1003895590
Payments from drug & device makers
Across 1,277 payments — averaging $4066.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3.7M
- Bristol Myers Squibb$261K
- Gilead$218K
- Roche Products Limited$215K
- Janssen Research & Development, LLC$206K
- Takeda Pharmaceuticals U.S.A., Inc.$194K
- plus $363K from 20 others
Across 36 payments — averaging $1494.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$39K
- E.r. Squibb & Sons, L.L.C.$8K
- Genentech, Inc.$6K
- UCB, Inc.$820
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 732 | $3,733,592 |
| Bristol Myers Squibb | 27 | $260,925 |
| Gilead | 54 | $218,418 |
| Roche Products Limited | 92 | $215,375 |
| Janssen Research & Development, LLC | 60 | $206,433 |
| Takeda Pharmaceuticals U.S.A., Inc. | 160 | $194,350 |
| UCB Biosciences Inc. | 4 | $104,496 |
| Genentech, Inc. | 22 | $66,335 |
| E.r. Squibb & Sons, L.L.C. | 10 | $38,735 |
| Eli Lilly | 21 | $35,500 |
| Johnson & Johnson | 37 | $31,028 |
| AstraZeneca | 4 | $25,775 |
| Janssen Global Services, LLC | 12 | $17,664 |
| Pfizer | 11 | $11,955 |
| Janssen Scientific Affairs, LLC | 9 | $6,276 |
| Merck | 6 | $6,078 |
| Lilly USA, LLC | 2 | $5,850 |
| Celltrion USA Inc. | 3 | $2,865 |
| Boehringer Ingelheim | 1 | $2,600 |
| UCB, Inc. | 2 | $2,600 |
| Celltrion Healthcare Co., Ltd | 2 | $2,000 |
| Boehringer Ingelheim International GmbH | 1 | $1,600 |
| Amgen | 2 | $1,250 |
| Fresenius Kabi USA, LLC | 1 | $610 |
| Steris Corporation | 1 | $101 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
How this compares
$5,192,429 in reported general payments places this provider in the 95th percentile of 365 gastroenterology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Rochester
- Andres AcostaRochester$2.8M
- Madhusudan GroverRochester$2.5M
- Michael CamilleriRochester$1.9M
- Vinay ChandrasekharaRochester$1.8M
- Joseph MurrayRochester$1.2M
- Sahil KhannaRochester$1.2M
- Alina AllenRochester$986K
- John KisielRochester$856K
- Ibrahim HanounehRochester$828K
- Douglas SimonettoRochester$542K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.